Amneal Launches FDA-Approved Lanreotide Injection in the US
Amneal Pharmaceuticals has launched lanreotide injection in the US following FDA approval, expanding its complex injectable medicines portfolio.
Lanreotide Injection | 28/09/2026 | By News Bureau
Cipla Gets Final FDA Approval for Lanreotide Injection
Cipla Ltd. has received the final approval for its Abbreviated New Drug Application (ANDA) for Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL from the United States Food and Drug Administration (US FDA).
Lanreotide Injection | 23/05/2024 | By Aishwarya | 1665
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy